MiNK Therapeutics stock soars after cancer remission breakthrough
MiNK Therapeutics stock soars after cancer remission breakthrough
Source link
Similar Posts
REMX – VanEck Rare Earth and Strategic Metals ETF
On the NYSE. https://www.vaneck.com/us/en/investments/rare-earth-strategic-metals-etf-remx/overview/ Net Expense Ratio 0.58% Pre market up 9.2% ATM. Source link
General Mills: Short-Term Downgrade After Significant Outperformance (NYSE:GIS)
photokitchen/iStock via Getty Images Revisiting Successful GIS Coverage In my first coverage of GIS two months ago in June, I argued that it is not suitable for a portfolio aimed at seeking Alpha. GIS serves different purposes, being highly uncorrelated with the overall market, as evidenced by its raw Beta factors hovering around zero. Therefore,…
Swiss Re Stock: Fair Valuation For This 5.4% Yielder (OTCMKTS:SSREF)
designer491 Swiss RE (OTCPK:SSREF) has reported a positive operating performance in recent quarters, but its valuation seems to be fair and upside potential seems limited right now. As I’ve covered in previous articles, I see Swiss Re as a good income investment in the European insurance sector, as the company offers a high-dividend yield that…
Riding the Market Waves: How the Moving Average Trend Following Strategy Keeps You from Drowning!
Trend-following strategies are effective tools for identifying and tracking price movements in the market. This article examines the MACD strategy and moving averages, highlighting key points on risk management and setting stop-loss orders. By leveraging these approaches, traders can make better decisions and enhance their performance. Overview of Trend-Following Strategies Trend-following approaches employ a methodical…
